Aspen Allergy Conference 2019
The Aspen Allergy Conference is a four consecutive half-day and thematic meeting to foster didactic lectures in an interactive format with the attendees. There is a maximum capacity of approximately 175 attendees in the lecture hall. This allows a very intimate setting for learning. The Aspen Allergy Conference is structured to host three State of the Art speakers from around the United States and abroad each day.
Registration Information
Registration fee information follows.
Registrant Type | Fee |
Colorado Allergy Society Member | FREE |
Physician | $400 |
Physician Assistant | $400 |
Online registration will close at 4:00 p.m. on Friday, July 19. On-site registration will open on the afternoon of Sunday, July 28 at Hotel Jerome.
Please click the Venue tab for accommodation information.
Credit Claiming
Credit claiming should open no later than 12:00 p.m. on Monday, August 5, 2019 and will remain open through 11:59 pm on Tuesday, June 30, 2020. Credit claiming requests on or after July 1, 2020 will be subject to an administrative fee.
Commercial Support
Aspen Allergy Conference is supported by educational grants from Stallergenes Greer, Lincoln Diagnostics, and the Colorado Allergy & Asthma Society.
Target Audience
- A/I Physicians
- Fellows-in-Training
- Nurse Practitioners
- Physician Assistants
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe best use of prescribing inhaled steroids in severe asthma
- Effectively treat pediatric asthma
- Evaluate and treat EGPA
- Understand the role of barriers and Type 2 inflammation in atopic dermatitis
- Diagnose and treat atopic dermatitis in the clinical setting
- Recognize treatment options for serious inflammatory disorders
- Describe the best treatment of allergic disease
- Understand new mechanisms of and treatment modalities for hereditary angioedema
- Describe the phenotypes in the upper airway
- Describe the best new treatments for nasal polyposis
- Determine treatment algorithms for aspirin-exasperated respiratory disease
Planning Committee
Fred (Dan) Atkins, MD FAAAAI
Children's Hospital of Colorado, Aurora, CO
Relevant relationships: None
Donna Bratton, MD
National Jewish Health, Denver, CO
Relevant relationships: None
Richard Weber, MD FAAAAI
Retired Physician
Relevant relationships: None
Stephen Dreskin, MD PhD FAAAAI
University of Colorado, Aurora, CO
Relevant relationships: None
Flavia Hoyte, MD
National Jewish Health, Denver, CO
Relevant relationships: None
John James, MD FAAAAI
Colorado Allergy and Asthma Centers, PC, Fort Collins, CO
Relevant relationships: None
Charles Kirkpatrick, MD FAAAAI
University of Colorado Health Sciences Center, Denver, CO
Relevant relationships: None
Harold Nelson, MD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: None
David Pearlman, MD FAAAAI
Colorado Allergy and Asthma Centers, Denver, CO
Relevant relationships: None
Lanny Rosenwasser, MD FAAAAI
Overland Park, KS
Relevant relationships: None
Alan Schocket, MD MSHA
University of Colorado, Denver, CO
Relevant relationships: None
Gary Siegel, MD
Denver Allergy and Asthma, Lakewood, CO
Relevant relationships: None
William Silvers, MD FAAAAI
University of Colorado, Denver, CO
Relevant relationships: None
Faculty
Eugene Bleecker, MD FAAAAI
University of Arizona, Tucson, AZ
Relevant relationships: AstraZeneca, GSK, Novartis, Regeneron, Sanofi Genzyme (consultant)
Mark Boguniewicz, MD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: Regeneron, Sanofi (advisory board); Regeneron (speaker: dupliumab), Regeneron (research grant)
Larry Borish, MD FAAAAI
University of Virginia, Charlottesville, VA
Relevant relationships: Allakos, AstraZeneca, Regeneron-Sanofi, Novartis (consultant); AstraZeneca, GSK (research grant)
Joshua Boyce, MD FAAAAI
Harvard Medical School and Brigham and Women's Hospital, Boston, MA
Relevant relationships: None
Talal Chatila, MD MSc
Harvard Medical School and Boston Children's Hospital, Boston, MA
Relevant relationships: None
Lawrence Eichenfield, MD
University of California San Diego, San Diego, CA
Relevant relationships: Leo Pharma, Lilly Pharma, Demira, Sanofi Genzyme/Regeneron (consultant); Pfizer (research grant)
Bob Geng, MD
University of California San Diego, San Diego, CA
Relevant relationships: Optinose, Regeneron, Horizon, CSL Behring (speaker); Pharming, Shire (advisory board); Stallergenes, Octoapharma, GSK, Genentech (research grant); Novartis (consultant)
Shikha Gupta, MD
National Jewish Health, Denver, CO
Relevant relationships: None
Carolina Gutierrez, MD
University of Colorado, Denver, CO
Relevant relationships: None
Hal Hoffman, MD FAAAAI
University of California, San Diego
Relevant relationships: Novartis (consultant: IL-1 therapy)
Donald Leung, MD PhD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: Abbvie, Aimmune, Incyte, Novartis, Regeneron, Sanofi, Pfizer (advisory board)
Wanda Phipatanakul, MD MS FAAAAI
Boston Children's Hospital, Boston, MA
Relevant relationships: Genentech, Novartis, Teva, Regeneron/Sanofi, GSK (advisory board)
Ronald Simon, MD FAAAAI
Scripps Clinic, San Diego, CA
Relevant relationships: None
Michael Wechsler, MD
National Jewish Health, Denver, CO
Relevant relationships: Genentech, Pulmatrix, Gala Therapeutics, Mylan, Boston Scientific, Boehringer Ingelheim, Novartis, Regeneron, Teva, Genzyme, AstraZeneca, Sanofi, GKS (consultant); Sentien (advisory board)
Bruce Zuraw, MD
University of California San Diego and San Diego VA Medical Center, San Diego, CA
Relevant relationships: BioCryst, Sanofi-Aventis, CSL Behring, Shire, Novartis (consultant)
Content Reviewer
Thomas Miller, MD FAAAAI
Allergy Associates of Western Michigan, Grandville, MI
Relevant relationships: AstraZeneca: asthma
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment: Name of employer and job title.
- Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
- Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and the Aspen Allergy Conference. The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 16.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit Claiming Period
Credit claiming for this activity will expire at 11:59 pm on June 30, 2020. Requests to claim credit on or after July 1, 2020 will be subject to an administrative fee.
Medium and Method of Physician Participation for a Live Activity
Follow these steps to complete the activity:
- Register for the activity.
- Review the CME and Disclosure information.
- View any pre-meeting information and/or complete the pre-test, if available.
- Attend the meeting. Be sure to sign in so your attendance can be recorded.
- Return to the online meeting site after the meeting and complete the post-test, if required. You must achieve a score of 70% or higher on post-tests to claim credit.
- Complete the activity evaluation.
- Claim your credits. Enter only the number of credits earned based on your participation in the activity.
- Print or save your certificate.
AAAAI Privacy Policy
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.
Questions
Activity-related questions should be directed to Jill Hibbeln at jillhibbeln@gmail.com.
Registration and credit claiming questions should be directed to cme@aaaai.org.
Available Credit
- 16.00 AttendanceAttendance credit.
- 16.00 CMECME credit.